ursolic acid has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alshahrani, S; Tripathi, P | 1 |
| An, N; Cai, S; Pei, J; Peng, J; Wang, D; Wang, W; Wu, M; Zhan, X | 1 |
| Wang, W; Xu, CG; Zhou, XJ; Zhu, XL | 1 |
| Cho, HW; Kim, MJ; Lee, HI; Lee, J; Lee, MK; Park, EM; Seo, KI | 1 |
4 other study(ies) available for ursolic acid and Kidney Diseases
| Article | Year |
|---|---|
Mitigation of ILβ-1, ILβ-6, TNF-α, and markers of apoptosis by ursolic acid against cisplatin-induced oxidative stress and nephrotoxicity in rats.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Caspase 3; Caspase 9; Cisplatin; Gene Expression Regulation; Interleukin-1beta; Interleukin-6; Kidney Diseases; Male; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Triterpenes; Tumor Necrosis Factor-alpha; Ursolic Acid | 2021 |
The Protective Effect of Ursolic Acid on Unilateral Ureteral Obstruction in Rats by Activating the Nrf2/HO-1 Antioxidant Signaling Pathway.
Topics: Animals; Antioxidants; Fibrosis; Heme Oxygenase (Decyclizing); Kidney Diseases; NF-E2-Related Factor 2; Oleanolic Acid; Rats; Signal Transduction; Ureteral Obstruction; Ursolic Acid | 2022 |
Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo.
Topics: Actins; Animals; Cadherins; Cell Line; Collagen; Epithelial-Mesenchymal Transition; Fibronectins; Fibrosis; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice, Inbred C57BL; Random Allocation; RNA, Messenger; Signal Transduction; Snail Family Transcription Factors; Transforming Growth Factor beta1; Triterpenes; Ursolic Acid | 2019 |
Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dyslipidemias; Glucokinase; Glucose; Glucose Transporter Type 2; Glucose-6-Phosphatase; Glycogen; Hyperglycemia; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Mice, Inbred NOD; Polymers; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Triterpenes; Ursolic Acid | 2014 |